Resumen de acción 4013
La empresa Dr. Sulaiman Al Habib Medical Services Group crea, gestiona y explota hospitales, complejos médicos generales y especializados, centros de cirugía de día e instalaciones farmacéuticas en Arabia Saudí y en el extranjero.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 1/6 |
Competidores de Dr. Sulaiman Al Habib Medical Services Group Company
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | ر.س312.00 |
| 52 Week High | ر.س346.80 |
| 52 Week Low | ر.س223.20 |
| Beta | 0.68 |
| 1 Month Change | -3.76% |
| 3 Month Change | 2.97% |
| 1 Year Change | 5.12% |
| 3 Year Change | 108.56% |
| 5 Year Change | n/a |
| Change since IPO | 482.09% |
Noticias y actualizaciones recientes
Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
May 03
Subdued Growth No Barrier To Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Price
Apr 29There's Been No Shortage Of Growth Recently For Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Returns On Capital
Mar 15Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Dividend Will Be SAR1.15
Feb 22Recent updates
Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
May 03Subdued Growth No Barrier To Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Price
Apr 29There's Been No Shortage Of Growth Recently For Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Returns On Capital
Mar 15Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Dividend Will Be SAR1.15
Feb 22With EPS Growth And More, Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Makes An Interesting Case
Feb 20Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Price Is Out Of Tune With Earnings
Jan 09We Like These Underlying Return On Capital Trends At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013)
Nov 28We Think That There Are Issues Underlying Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Earnings
Nov 07Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Shareholders Will Receive A Bigger Dividend Than Last Year
Nov 02Here's Why Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Has Caught The Eye Of Investors
Sep 21Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is Doing The Right Things To Multiply Its Share Price
Aug 10Here's Why We Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is Well Worth Watching
Jun 17Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Shareholders Will Receive A Bigger Dividend Than Last Year
May 12Returns At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Are On The Way Up
May 06Here's Why We Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Might Deserve Your Attention Today
Mar 13Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Returns On Capital Are Heading Higher
Jan 30With EPS Growth And More, Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Makes An Interesting Case
Dec 07Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is Doing The Right Things To Multiply Its Share Price
Oct 23If EPS Growth Is Important To You, Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Presents An Opportunity
Sep 08Estimating The Intrinsic Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
Aug 24Why Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Could Be Worth Watching
Aug 08Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Has More To Do To Multiply In Value Going Forward
Jul 12Does Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Deserve A Spot On Your Watchlist?
May 31A Look At The Fair Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
May 17Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Will Pay A Larger Dividend Than Last Year At ر.س0.83
Apr 28Should You Think About Buying Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Now?
Apr 09Return Trends At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Aren't Appealing
Mar 06Here's Why I Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is An Interesting Stock
Feb 16Returns On Capital At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Have Stalled
Dec 05Do Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Earnings Warrant Your Attention?
Nov 17Investors Could Be Concerned With Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Returns On Capital
Aug 30Here's Why I Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Might Deserve Your Attention Today
Aug 01Estimating The Fair Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
Jun 11Capital Allocation Trends At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Aren't Ideal
May 27Earnings Beat: Dr. Sulaiman Al Habib Medical Services Group Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Apr 27Here's Why I Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Might Deserve Your Attention Today
Apr 06A Look At The Fair Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
Feb 04Is Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Shareholder Ownership Skewed Towards Insiders?
Jan 14
Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Is Yielding 1.5% - But Is It A Buy?
Dec 23Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Nov 27Rentabilidad de los accionistas
| 4013 | SA Healthcare | Mercado SA | |
|---|---|---|---|
| 7D | -1.6% | -0.3% | -0.1% |
| 1Y | 5.1% | 13.2% | -2.5% |
Rentabilidad vs. Industria: 4013 obtuvo unos resultados inferiores a los del sector SA Healthcare , que el año pasado arrojó un rendimiento del 14.6%.
Rentabilidad vs. Mercado: 4013 superó al mercado SA, que obtuvo un rendimiento del -2.6% el año pasado.
Volatilidad de los precios
| 4013 volatility | |
|---|---|
| 4013 Average Weekly Movement | 3.0% |
| Healthcare Industry Average Movement | 4.6% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in SA Market | 8.0% |
| 10% least volatile stocks in SA Market | 2.6% |
Precio estable de las acciones: 4013 no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de 4013 (3%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1993 | n/a | Faisal Abdullah Al Nassar | www.hmg.com |
La empresa Dr. Sulaiman Al Habib Medical Services Group crea, gestiona y explota hospitales, complejos médicos generales y especializados, centros de cirugía de día e instalaciones farmacéuticas en Arabia Saudí y en el extranjero. Gestiona hospitales de maternidad, ortopedia y cirugía de la columna vertebral. También gestiona centros de dermatología, cirugía plástica, oftalmología, tratamiento de la obesidad y fertilidad, así como farmacias.
Resumen de fundamentos de Dr. Sulaiman Al Habib Medical Services Group Company
| Estadísticas fundamentales de 4013 | |
|---|---|
| Capitalización bursátil | ر.س109.06b |
| Beneficios(TTM) | ر.س2.11b |
| Ingresos (TTM) | ر.س9.72b |
51.8x
Ratio precio-beneficio (PE)11.2x
Ratio precio-ventas (PS)¿Está 4013 sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de 4013 | |
|---|---|
| Ingresos | ر.س9.72b |
| Coste de los ingresos | ر.س6.38b |
| Beneficio bruto | ر.س3.35b |
| Otros gastos | ر.س1.24b |
| Beneficios | ر.س2.11b |
Últimos beneficios comunicados
Mar 31, 2024
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 6.02 |
| Margen bruto | 34.43% |
| Margen de beneficio neto | 21.68% |
| Ratio deuda/patrimonio | 80.1% |
¿Cómo se ha desempeñado 4013 a largo plazo?
Ver rendimiento histórico y comparativa